Panaxadiol from Panax ginseng C.A. Meyer Inhibits Synthesis of Thromboxane $A_2$ in Platelet Aggregation Induced by Thrombin

고려인삼의 파낙사다이올은 트롬빈 유인 혈소판응집반응에서 트롬복산 A2의 생성을 저해한다

  • Park, Hwa-Jin (Department of Biochemical Pharmacology, Korea Ginseng & Tobacco Research Institute) ;
  • Rhee, Man-Hee (Department of Biochemical Pharmacology, Korea Ginseng & Tobacco Research Institute) ;
  • Park, Kyeong-Mee (Department of Biochemical Pharmacology, Korea Ginseng & Tobacco Research Institute) ;
  • Nam, Ki-Yeul (Department of Biochemical Pharmacology, Korea Ginseng & Tobacco Research Institute) ;
  • Park, Ki-Hyun (Department of Biochemical Pharmacology, Korea Ginseng & Tobacco Research Institute)
  • Published : 1993.08.01

Abstract

Panaxadiol (PD) from Korean red ginseng C.A. Meyer did not control the concentration of cytosolic free $Ca^{2+}$ influxes by thrombin (5 $\mu$/ml). However, PD strongly inhibited the synthesis of thromboxane. $A_2$ (TX$A_2$) in the aggregation of human platelets induced by thrombin (5 $\mu$/ml). These rexults suggest that PD blocks the any Pathway transforming to TX$A_2$ from arachidonic acid (AA) which release out of plasma membrane phospholipids by $Ca^{2+}$-dependent phospholipase C or phospholipase $A_2$. It may be also concluded that PD has the antiplatelet function by inhibiting the synthesis of TX$A_2$, which known to be the potent stimulator of the aggregation of human platelet.

Keywords